Lars Weidolf

3.9k citations
61 papers · 3.2k · 1 hit paper · h-index 29

Impact in

  • Pharmacology top 0.2%
    • Pharmacogenetics and Drug Metabolism
    • Drug-Induced Hepatotoxicity and Protection
    • Gastroesophageal reflux and treatments

Papers in

    • Pharmacogenetics and Drug Metabolism 29
    • Drug-Induced Hepatotoxicity and Protection 8
    • Plant-based Medicinal Research 5

Lars Weidolf

59 papers receiving 3.0k citations

Lars Weidolf's Hit Papers

COMPARISON OF INHIBITORY EFFECTS OF THE PROTON PUMP-INHIBITING DRUGS OMEPRAZOLE, ESOMEPRAZOLE, LANSOPRAZOLE, PANTOPRAZOLE, AND RABEPRAZOLE ON HUMAN CYTOCHROME P450 ACTIVITIES 2004 · 511 citations
5110+7+14Years since publication100200300400500

Peers

Lars Weidolf
Comparison fields: 5 of 132
  • Pharmacology 936
  • Gastroenterology 290
  • Pharmaceutical Science 291
  • Spectroscopy 605
  • Analytical Chemistry 257
Replace Inger Skånberg with:
Inger Skånberg Sweden
Dafang Zhong China
Pavel Anzenbacher Czechia
Tommy B. Andersson Sweden
Xiaoyan Chen China
Ute Hofmann Germany
Kiyohiko Sugano Japan
C G Regårdh Sweden
Sibylle Neuhoff United Kingdom
Henning Blume Germany
Lars Weidolf relative to Inger Skånberg Sweden Inger Skånberg's profile →
Citations per field
00.5×
Inger Skånberg · 1×
Citations per year

Countries citing papers authored by Lars Weidolf

Since Specialization
Citations

This map shows the geographic impact of Lars Weidolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Weidolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Weidolf more than expected).

Fields of papers citing papers by Lars Weidolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Weidolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Weidolf. The network helps show where Lars Weidolf may publish in the future.

Co-authors

The 25 scholars most cited alongside Lars Weidolf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lars Weidolf Line = papers co-authored together Lars Weidolf links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.

#Work
1
COMPARISON OF INHIBITORY EFFECTS OF THE PROTON PUMP-INHIBITING DRUGS OMEPRAZOLE, ESOMEPRAZOLE, LANSOPRAZOLE, PANTOPRAZOLE, AND RABEPRAZOLE ON HUMAN CYTOCHROME P450 ACTIVITIES
Hit paper breakdown →
2004511
2 2012245
3 2000237
4 2001202
5 2003185
6 2012168
7 2007119
8 1987118
9 200796
10 198893
11 200880
12 201078
13 200871
14 200968
15 200862
16 201253
17 201351
18 201848
19 200848
20 201547

About Lars Weidolf

Lars Weidolf is a scholar working on Pharmacology, Molecular Biology, Spectroscopy, Oncology and Computational Theory and Mathematics, having authored 61 papers that have together received 3.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (29 papers), Analytical Chemistry and Chromatography (12 papers), Drug Transport and Resistance Mechanisms (12 papers), Drug-Induced Hepatotoxicity and Protection (8 papers), Computational Drug Discovery Methods (7 papers), Mass Spectrometry Techniques and Applications (6 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Plant-based Medicinal Research (5 papers). The work is most often cited by research in Pharmacology (936 citations), Gastroenterology (290 citations), Pharmaceutical Science (291 citations), Spectroscopy (605 citations) and Analytical Chemistry (257 citations). Lars Weidolf has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Tommy B. Andersson, Ulrik Jurva, Xueqing Li, Tommy Andersson, Emre M. Isin, Jack D. Henion, Andries P. Bruins, Richard A. Thompson, Tove Johansson and Madeleine Antonsson. Their work appears in journals such as Drug Metabolism and Disposition, Chemical Research in Toxicology, Rapid Communications in Mass Spectrometry, Xenobiotica and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact